(Q43158772)

English

Thiazolidinediones alter growth and epithelial cell integrity, independent of PPAR-γ and MAPK activation, in mouse M1 cortical collecting duct cells

scientific article published on 17 February 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Thiazolidinediones alter growth and epithelial cell integrity, independent of PPAR-γ and MAPK activation, in mouse M1 cortical collecting duct cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2018

author name string

Rania Nasrallah

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Jordan Clark

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Jaime Corinaldi

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Geneviève Paris

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Bernard J Jasmin

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Richard L Hébert

7

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

publication date

17 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

298

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

F1105-12

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Thiazolidinediones in dermatology

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Effects of thiazolidinediones on differentiation, proliferation, and apoptosis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

The PPARδ ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

An overview on biological mechanisms of PPARs.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Expression profile of genes regulated by activity of the Na-H exchanger NHE1

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Characterization of a mouse cortical collecting duct cell line.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

A role for Wnt-4 in renal fibrosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Troglitazone induces a cellular acidosis by inhibiting acid extrusion in cultured rat mesangial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Role of PPARgamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00735.2009

21 January 2018

Identifiers

10.1152/AJPRENAL.00735.2009

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

release_2mzkfx6gmvgmtn45l7hqjtvpwa

1 reference

https://api.fatcat.wiki/v0/release/2mzkfx6gmvgmtn45l7hqjtvpwa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43158772&oldid=1982354244"